AzTrials
AzTrials

Ischemic StrokeIndiQ-AVCNCT06638242

Indicators of Quality Care and Services for Adults With Acute Ischemic Stroke in Different Types of Hospitals in Quebec : Research Protocol

An observational study of Ischemic Stroke, run by Amelie Belanger at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this study is to describe the performance of care and services offered to people hospitalized with ischemic stroke. More specifically, this study aims to answer the following questions: Is stroke care and service delivered to the population optimally? Are these services equitable, regardless of the… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Ischemic Stroke
How many people
132 participants
Where
1 siteCanada
Study dates
8 Jun 2022to 1 Oct 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adults with ischemic stroke All persons hospitalized for ischemic stroke within the 6 months preceding approval of the Research Ethics Board (REB). The study will be conducted based on their health records.

Who may be able to join

  • Adults 18 years old or over with ischemic stroke requiring hospitalization in an acute care unit or special stroke unit

Who cannot join

  • Adults with hemorrhagic stroke

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Centre intégré universitaire de santé et services sociaux de la Mauricie et du Centre-du-Québec

    Trois-Rivières, Quebec, G8Z 3R9

Other trials in Canada

About this study

Official title: Indicators of Quality Care and Services for Adults With Acute Ischemic Stroke in Different Types of Hospitals in Quebec (IndiQ-AVC) : Research Protocol

The goal of this study is to describe the performance of care and services offered to people hospitalized with ischemic stroke. More specifically, this study aims to answer the following questions:

  • Is stroke care and service delivered to the population optimally?
  • Are these services equitable, regardless of the hospital where the patient is hospitalized?
  • Are all patients treated in the same way, regardless of individual characteristics such as age, sex or risk factors?

An evaluation of the quality of practices will be carried out on the health records of patients hospitalized in different hospital centers in Quebec such as a subspecialized center, a regional center and a center in a remote region. An in-depth analysis will also be conducted to determine whether certain individual patient characteristics may influence how they are managed during a stroke.

Conditions
Ischemic Stroke
Keywords
clinical and organizational quality incdicators, practices assessment, stroke acute phase, interdisciplinarity
Medical subject headings
Ischemic Stroke

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Descriptives analyses

    Descriptive analyses will be completed to assess clinical and organizational practices in hospital centers from patients'health records

    Measured: All persons hospitalized for ischemic stroke within the 6 months preceding approval of the Research Ethics Board (REB).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Oct 2024
  2. Study start8 Jun 2022
  3. Primary completion1 Oct 2024
  4. Study completion1 Oct 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Retrospective
Enrolment
132 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06638242
Sponsor's protocol ID
MP-29-2022-606
Acronym
IndiQ-AVC
Status last verified
Oct 2024
First submitted
9 Oct 2024
Last updated
15 Oct 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Ischemic Stroke, run by Amelie Belanger at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Descriptives analyses (time frame: All persons hospitalized for ischemic stroke within the 6 months preceding approval of the Research Ethics Board (REB).). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in